Funding profile · Psychiatry health IT

Osmind

Osmind raised $57 million between 2020 and May 2022 and has announced nothing since. Its own SEC record is empty: every Form D naming the company was filed by somebody else’s vehicle.

$57.0MTotal raised since 2020, company-reported
$40.0MSeries B, May 2022, led by DFJ Growth
$1.42MVisible in SEC Form D filings, all third party SPVs, about 3.6% of the Series B
0Form D filings by Osmind Inc. itself

Data as of September 23, 2026. Company-reported figures are labeled.

Rounds at a glance

When Round Amount Investors Source
2020 Y Combinator and pre-seed Part of a $2.2M total Y Combinator, Pear VC Reported
Oct 2020 Seed $2.0M General Catalyst (lead), What If Ventures, 20|20 Fund, Jeffrey Leiden Reported
Jul 2021 Series A $15.0M Future Ventures (lead), General Catalyst, Tiger Global, Offline Ventures, AME Cloud Ventures, plus angels Company release
Mar to May 2022 Five SPVs buying into the Series B $1,420,592 Gaingels, What If Ventures (two series), Leiter Chu LLC, V360 Holdings Form D
May 2022 Series B $40.0M DFJ Growth (lead), Susa Ventures, Lachy Groom, Brent Saunders, Helena Goodman, Ariel Katz; existing investors followed on Company release
Since May 2022 No round announced or filed None None Not found

What the filings show

Gaingels Osmind LLC · Form D · filed Mar 28, 2022

First sale
Mar 18, 2022
Type
Industry group “Other,” not a pooled fund
Sold
$412,000 of $412,000
Investors
19 · average about $21,700
Exemption
Rule 506(b)
Related persons
David Beatty (executive officer), Vermont
Filing
SEC EDGAR, CIK 0001917969

What If Ventures Osmind, a series of What If SPV LLC · Form D · filed Mar 24, 2022

First sale
Mar 24, 2022
Type
Pooled investment fund, venture capital fund
Sold
$506,000 of $506,000
Investors
11 · average $46,000
Minimum
$5,000
Exemptions
Rule 506(b); Investment Company Act 3(c)(1)
Related persons
What If Capital Management, LLC (promoter); Stephen Hays (executive officer)
Filing
SEC EDGAR, CIK 0001918827

Osmind Series B, a series of Leiter Chu LLC · Form D · filed Mar 28, 2022

First sale
Mar 28, 2022
Type
Pooled investment fund, venture capital fund
Sold
$105,000 of $105,000
Investors
4 · average $26,250
Minimum
$10,000
Exemptions
Rule 506(b); Investment Company Act 3(c)(1)
Related persons
Christopher Leiter (promoter)
Filing
SEC EDGAR, CIK 0001919123

What If Ventures Osmind 2022, a series of What If SPV LLC · Form D · filed Jun 3, 2022

First sale
Apr 13, 2022
Type
Pooled investment fund, other investment fund
Sold
$162,592 of $162,592
Investors
11 · average about $14,800
Minimum
$5,000
Exemptions
Rule 506(b); Investment Company Act 3(c)(1)
Related persons
What If Ventures LLC (promoter)
Filing
SEC EDGAR, CIK 0001929492

V360 Holdings LLC Series Osmind Fund I · Form D · filed Mar 3, 2025

First sale
May 18, 2022
Type
Pooled investment fund, venture capital fund
Sold
$235,000 of $235,000
Investors
23 · average about $10,200
Minimum
$5,000
Exemption
Rule 506(b)
Related persons
Martin Rudigier (promoter), San Francisco
Filing
SEC EDGAR, CIK 0002057215

Reading the filings

  1. The company has never filed for itself.There is no Osmind Inc. CIK in EDGAR and no Form D under the company name. All five filings naming Osmind were made by other people’s vehicles. Issuers raising under Section 4(a)(2) rather than Regulation D file no Form D, so the absence does not mean no money moved. It does mean EDGAR accounts for $1,420,592 of a reported $57 million, about 2.5% of the total and 3.6% of the Series B.
  2. The round was funded well before it was announced.The earliest first sale is March 18, 2022. The Series B was announced on May 10, 53 days later. Four of the five vehicles had already taken money before the press release; the fifth took its first eight days after.
  3. These are small checks in volume, not institutional allocations.$1,420,592 across 68 investors averages about $20,900 each, from roughly $10,200 at V360 to $46,000 at the first What If series. Stated minimums were $5,000, except Leiter Chu at $10,000. That is syndicate and angel money riding alongside DFJ Growth.
  4. One filing is nearly three years late.V360 Holdings reported a first sale of May 18, 2022 and filed on March 3, 2025, about 33 months later. Form D is due within 15 days of first sale. Nothing explains the delay.
  5. One sponsor, two vehicles, two months apart.What If Ventures filed one series in March 2022 and a second, Osmind 2022, in June for an April first sale, classified as an other investment fund rather than a venture capital fund. Together they moved $668,592 from 22 investors, the largest sponsor position in the record.
  6. The paper trail stops.No round has been announced since May 2022 and none filed since March 2025. Reporting still cited the same $57 million total in December 2024. The filings do not say whether that reflects a company funding itself from revenue or a financing that has not surfaced.

Commercial signals

Signal Detail Source type
Practices 30 (Aug 2020), 125+ in 30 states (Oct 2020), 215+ in 38 states (Jul 2021), 400+ in 45 states (early 2023), 800+ (Jan 2025), 1,000+ (2026). Company-stated
Published pricing EHR at $249 per clinician per month; $4 per automated Spravato REMS submission; $49 per clinician per month for controlled substance e-prescribing. Two higher tiers take a percentage fee and add payer contracts, credentialing, revenue cycle management and group purchasing. Company-stated
Evidence output Four peer reviewed papers using platform data, 2022 to 2026, plus a September 2026 Nature Mental Health comment co-authored with former NIMH director Thomas Insel, who discloses equity. Public record
Named customers None found. Not found
Certified health IT No Certified Health IT Product List entry found. Not found

What to watch

  • A Form D under an Osmind Inc. CIK, which would be its first direct filing.
  • Any amendment from V360 Holdings explaining the 33 month filing gap.
  • Whether the $57 million total is ever revised. It was unchanged from May 2022 through December 2024.
  • A CHPL certification listing.

The Osmind story on Healthcare DiscoveryHealthcare Discovery

Related companies

  • DrChrono: Shared investor: General Catalyst. An electronic health record built for the iPad in 2010 and sold to EverCommerce in November 2021 for $181.9 million in cash
  • Memora Health: Shared investor: General Catalyst. A text messaging platform that automated patient follow up for Mayo Clinic, Penn Medicine and more than fifty other provider organizations
  • Sohar Health: Shared investor: General Catalyst. An API that tells a behavioral health clinic, in about six seconds, whether a patient’s insurance will actually pay
  • Medplum: Shared investor: Gaingels. An open source, FHIR native electronic health record that developers install instead of licensing

Sources

  1. Public recordForm D, Gaingels Osmind LLCSEC · Mar 28, 2022
  2. Public recordForm D, What If Ventures Osmind and Osmind 2022SEC · Mar 24 and Jun 3, 2022
  3. Public recordForm D, Osmind Series B, a series of Leiter Chu LLCSEC · Mar 28, 2022
  4. Public recordForm D, V360 Holdings LLC Series Osmind Fund ISEC · Mar 3, 2025
  5. Public recordEDGAR company search for Osmind, all filing typesSEC · searched Sep 23, 2026
  6. IndependentOsmind banks $40M to scale up EHR for mental health providersFierce Healthcare · May 16, 2022
  7. IndependentOsmind CEO Lucia Huang on mental health softwareSF Business Times · Dec 10, 2024
  8. CompanyOsmind Raises $40M Series B Round Led by DFJ GrowthBusiness Wire · May 10, 2022
  9. CompanyOsmind Appoints Dr. William Sauvé as Chief Medical OfficerBusiness Wire via BioSpace · Jan 16, 2025
  10. CompanyOsmind pricing and plans pageosmind.org · accessed Sep 23, 2026

Compiled from SEC and other public records and published reports as of September 23, 2026. Form D notices report offerings under Regulation D; amounts reflect the filing date and may not capture later sales. Healthcare Venture Capital Fund holds no position in Osmind. This page is not an offer to sell or a recommendation to buy any security.